• Search Funds
  • Model Portfolios
  • Provider
  • Sector
  • Manager

Search by provider name

Search by sector name

Search by manager name

Search by Risk Level

Schroder Global Healthcare Z Acc

  • Fund Info & charges
  • Performance
  • Fund breakdown
  • Dividend History
Fund Provider Schroders
Fund Summary The Fund aims to provide capital growth by investing in equity and equity related securities of healthcare and medical related companies worldwide.
SEDOL code B76V7Q0
ISIN GB00B76V7Q08
Fund code SZMDA
Managers John Bowler
Manager Tenure 15 years
Morningstar Category Sector Equity Healthcare
IMA Sector Global
Fund Size £254 million
Fund Type OEIC
Management Style Active
Total Expense Ratio (TER) 0.92%
Cavendish ongoing charge 0.05%
FundsNetwork Service Fee 0.20%
Minimum Initial Investment £25
Minimum Top Up £25
Minimum Monthly Investment £25
Sell Price £1.733
Buy Price £1.733
Price Change -0.9714%
Price Date 23rd August 2019
Yield 0.47%
Dividend Frequency Yearly
ISA Eligible Yes
SIPP Eligible Yes
Inception Date 12th June 2000
Fund Status OPEN
John Bowler is a Fund Manager and Global Sector Specialist at Schroders, which involves covering the healthcare sector and manager of the Schroder Global Healthcare Fund, as well as having primary research responsibility for Pan-European pharmaceuticals. He joined Schroders in 2003 and is based in London. Qualifications: BA in Biology from the University of Manchester.

3-year Mean Monthly Return: 0.857%

Annual Returns 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009
Fund Performance +13.24% +4.49% +13.89% +11.81% +24.53% +18.29% +31.49% +5.76% +18.17% +17.13%
Benchmark Performance
(Sector Equity Healthcare)
+8.25% +6.21% +10.46% +12.41% +21.90%
Time Period Cumulative Benchmark Performance
(Sector Equity Healthcare)
Fund Compared to Benchmark
1 day -0.97% -0.15% -0.82%
1 week 0.46% +1.50% -1.04%
1 month 1.52% +3.69% -2.16%
3 months 8.79% +1.52% +7.27%
6 months 9.96% +1.20% +8.76%
1 year 7.98% +6.07% +1.90%
3 years 33.10% +35.37% -2.26%
5 years 88.00% +72.45% +15.55%
10 years 315.71% +284.71% +31.00%
YTD 16.70% +8.18% +8.52%
Since inception 335.31% Currently unavailable Currently unavailable

Top 10 shares for this fund

Share Name Country Value
Merck & Co Inc USA 6.91%
Novartis AG CHE 6.13%
UnitedHealth Group Inc USA 5.70%
Roche Holding AG Dividend Right Cert. CHE 5.40%
Abbott Laboratories USA 4.83%
Eli Lilly and Co USA 4.79%
Thermo Fisher Scientific Inc USA 4.05%
Takeda Pharmaceutical Co Ltd JPN 3.64%
Anthem Inc USA 3.64%
Baxter International Inc USA 3.56%
Dividend Date Per share amount Reinvestment Price
16th August 2019 0.0072 £1.7250
16th August 2018 0.0074 £1.6020
16th August 2017 0.0066 £1.3940
16th August 2016 0.0091 £1.3280
17th August 2015 0.0056 £1.1400
18th August 2014 0.0059 £0.9024